Cavalcanti S M, Deus F C, Zardo L G, Frugulhetti I C, Oliveira L H
Departamento de Microbiologia e Parasitologia, Universidade Federal Fluminense, RJ, Brasil.
Mem Inst Oswaldo Cruz. 1996 Jul-Aug;91(4):433-40. doi: 10.1590/s0074-02761996000400009.
Two hundred and thirty paraffin-embedded biopsies obtained from female cervical lesions were tested for the presence of human papillomavirus (HPV) types 6/11, 16/18 and 31/33/35 DNA using non-isotopic in situ hybridization. Specimens were classified according to the Bethesda System in low grade squamous intraepithelial lesion (LSIL), high grade SIL (HSIL) and squamous cell carcinoma (SCC). HPV prevalence ranged from 92.5% in LSIL to 68.5% in SCC. Benign types were prevalent in LSILs while oncogenic types infected predominantly HSILs and SCC. HPV infection showed to be age-dependent, but no significant relation to race has been detected. Patients were analyzed through a five-year period: 20.7% of the lesions spontaneously regressed while 48.9% persisted and 30.4% progressed to carcinoma. Patients submitted to treatment showed a 19.4% recurrence rate. High risk types were present in 78.6% (CrudeOR 13.8, P = 0.0003) of the progressive lesions, and in 73.7% of the recurrent SILs (COR 19.3, P = 0.0000001). Possible co-factors have also been evaluated: history of other sexually transmitted diseases showed to be positively related either to progression (Adjusted OR 13.0, P = 0.0002) or to recurrence (AOR 17.2, P = 0.0002) while oral contraceptive use and tobacco smoking were not significantly related to them (P > 0.1). Association of two or more co-factors also proved to be related to both progression and recurrence, indicating that they may interact with HPV infection in order to increase the risk of developing malignant lesions.
采用非同位素原位杂交技术,对230例取自女性宫颈病变的石蜡包埋活检组织进行了人乳头瘤病毒(HPV)6/11型、16/18型及31/33/35型DNA检测。标本根据贝塞斯达系统分类为低级别鳞状上皮内病变(LSIL)、高级别鳞状上皮内病变(HSIL)和鳞状细胞癌(SCC)。HPV感染率从LSIL中的92.5%到SCC中的68.5%不等。良性HPV类型在LSIL中普遍存在,而致癌型HPV主要感染HSIL和SCC。HPV感染显示出年龄依赖性,但未检测到与种族的显著相关性。对患者进行了为期五年的分析:20.7%的病变自发消退,48.9%持续存在,30.4%进展为癌症。接受治疗的患者复发率为19.4%。78.6%(粗比值比13.8,P = 0.0003)的进展性病变中存在高危型HPV,73.7%的复发性SIL中存在高危型HPV(校正比值比19.3,P = 0.0000001)。还评估了可能的协同因素:其他性传播疾病史显示与进展(校正比值比13.0,P = 0.0002)或复发(校正比值比17.2,P = 0.0002)均呈正相关,而口服避孕药使用和吸烟与它们无显著相关性(P > 0.1)。两种或更多协同因素的联合也被证明与进展和复发均相关,表明它们可能与HPV感染相互作用,以增加发生恶性病变的风险。